Publications by authors named "Areum Go"

Claim this Profile
D
Design, synthesis and biological evaluation of camptothecin analogue FL118 as a payload for antibody-drug conjugates in targeted cancer therapy.
Gangadhar Rao Mathi, Byeong Sung Lee, Younghwa Chun, Seunggun Shin, Sohui Kweon, Areum Go

Bioorg Med Chem Lett· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301.
Byungho Lim, Dabin Yoo, Younghwa Chun, Areum Go, Ji Yeon Kim

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia.
Byungho Lim, Dabin Yoo, Younghwa Chun, Areum Go, Kyung-Jin Cho

Blood Cancer J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.
Ji-Yong Yoon, Jeong-Ju Lee, Sujin Gu, Myoung Eun Jung, Hyun-Soo Cho, Areum Go

Oncotarget· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel [1,2,4]triazolo[4,3-a]quinoxaline aminophenyl derivatives as BET inhibitors for cancer treatment.
Imran Ali, Jooyun Lee, Areum Go, Gildon Choi, Kwangho Lee

Bioorg Med Chem Lett· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis